Rockefeller University
Clinical trials sponsored by Rockefeller University, explained in plain language.
-
New antibody shot aims to control hepatitis b in early trial
Disease control Recruiting nowThis early-stage study tests a single dose of a new antibody (HepB mAb19) in 37 adults with chronic hepatitis B who are already on standard antiviral pills. The main goals are to check safety and how the body processes the antibody, while also looking at its ability to lower viru…
Phase: PHASE1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Scientists dig deep into rare bleeding disorders to uncover genetic secrets
Knowledge-focused Recruiting nowThis study looks at how blood cells work together and what goes wrong in inherited bleeding disorders like Glanzmann thrombasthenia. Researchers will test blood from up to 60 healthy volunteers and patients to find genetic defects. The goal is to learn more about these conditions…
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC
-
Aspirin not always enough: study seeks answers for preeclampsia prevention failure
Knowledge-focused Recruiting nowThis study looks at why low-dose aspirin doesn't always prevent preeclampsia, a serious pregnancy complication. Researchers will study genetic and lab factors in 130 women who had preeclampsia before and took aspirin in a later pregnancy. The goal is to understand why aspirin wor…
Phase: EARLY_PHASE1 • Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated May 26, 2026 03:10 UTC